Inspection prep notes · Quality system
Training and job responsibilities
Also called: training, job description, personnel qualification
FDA looks less at whether a training procedure exists than at whether the person doing the job actually received the training it requires and whether records can show it. The findings below are quoted from warning letters and FDA 483s.
What inspectors cited
1Analysts and inspectors were not trained for the work they performed
QC analysts performing [redacted] testing have not completed mandatory training requirements per the firm's training procedure (Document No. RD-03-01-019, Revision W).
FDA 483 · Baxter Healthcare Corporation · 2026-10-30 · View document
However, visual inspectors are not trained on identification of API residue during visual inspection qualification.
FDA 483 · Imprimis NJOF, LLC · 2024-08-06 · View document
2CGMP training was not given on a regular basis
CGMP training is not regularly performed at your firm as required by your established procedure.
FDA Warning Letter · Microbiological Testing & Consulting, LLC · 2026-03-31
Your firm does not conduct periodic CGMP training for employees.
FDA 483 · RC Outsourcing LLC · 2026-10-06 · View document
3Training was not properly documented
For example, an analyst who performed unreported injections lacked documented laboratory training and CGMP training.
FDA Warning Letter · Shimoga Chemicals · 2026-07-21 · View document
Specifically, your firm failed to adequately document and verify training records for personnel involved in manufacturing, equipment, and cGMP training.
FDA 483 · Emcure Pharmaceuticals Limited · 2026-10-20
4Employees who needed retraining were not retrained
For example, we observed your failed training for #SD/PD/SOP028 Rev. 06 (Cleaning and Disinfection of Floor Drain, 04/26/2021 effective date) which was never repeated.
FDA 483 · Alembic Pharmaceuticals Limited · 2026-01-07 · View document
The Quality Unit has not assured that corrective action taken to retrain analysts in the dilution procedure for dissolution tests involving SLS was complete in that; for persons involved in the initial dissolution failure of Carbamezapine Tablets lots were not retrained until this inspection.
FDA 483 · Caraco Pharmaceutical Laboratories, Ltd. · 2025-06-30 · View document
5There was no evidence that the people doing the work were adequately trained
For example, your co-owner stated that he is the sole proprietor of the Magic Heal formulation, had full knowledge of the process, and performed all manufacturing operations. However, you lack evidence that your co-owner has the adequate experience to perform these functions nor has received the appropriate CGMP training.
FDA Warning Letter · Premier Trends LLC · 2022-03-22 · View document
There is no documentation to support that staff performing visual inspection of sterile injectable product, which comprises all pharmacists and technicians, have adequate training.
FDA 483 · Pharmagen Laboratories, Inc · 2024-01-17 · View document
Questions to check against your procedures
- Has everyone who performs a test or inspection completed all the training the procedure makes mandatory?
- Does the qualification training for visual inspectors cover the defects they actually have to judge?
- Is CGMP training given at the interval the procedure sets?
- Can each employee's training records be produced right away when asked for during an inspection?
- Are training records verified by the trainee who received the training?
- Are employees who failed a training or were involved in a failure retrained before they are assigned the work again?
Compiled by AI from public findings and checked by a person. Quotations are verbatim from the original documents; (b)(4) marks text redacted in the original. As of 2026-11-16.